Valuation: MedPacto, Inc.

Market Cap 87.4B 63.1M 54.01M 50.52M 46.24M 86.79M 6.03B 87.93M 597M 233M 3.03B 237M 232M 10.05B P/E 2024
-7.42x
P/E 2025 -17.9x
Enterprise Value 48.43B 34.97M 29.93M 27.99M 25.62M 48.09M 3.34B 48.72M 331M 129M 1.68B 131M 128M 5.57B EV / Sales 2024
-
EV / Sales 2025 48,733,025x
Free-Float
74%
Yield 2024 *
-
Yield 2025 -
1 day-1.54%
1 week-6.59%
Current month+8.51%
1 month-2.49%
3 months-36.25%
6 months-55.65%
Current year-61.83%
1 week 2,390
Extreme 2390
2,825
1 month 2,235
Extreme 2235
3,960
Current year 2,235
Extreme 2235
7,980
1 year 2,235
Extreme 2235
8,650
3 years 2,235
Extreme 2235
17,240
5 years 2,235
Extreme 2235
69,600
10 years 2,235
Extreme 2235
134,200
Manager TitleAgeSince
Chief Executive Officer 72 2013-06-18
President 66 2024-03-27
Comptroller/Controller/Auditor 70 2022-03-27
Director TitleAgeSince
Director/Board Member 72 2013-06-18
Director/Board Member 66 2024-03-27
Director/Board Member 64 2024-03-27
Date Insider Type Main position Quantity % Market Cap.
3/4/25 Buy 10,000 0.0292%
3/4/25 Buy 10,500 0.0306%
3/4/25 Buy

Chairperson

15,000 0.0438%
Change 5-day change 1-year change 3-year change Capi.($)
-1.54%-6.59%-34.95%-82.51% 63.72M
-3.00%+0.33%+77.39%+109.41% 73.96B
+1.90%+19.57%+60.16%+101.03% 64.66B
+0.55%-0.44%-2.84%+478.79% 27.32B
+5.12%+26.54%+4.73%+5.63% 27.86B
+2.74%+11.55%+66.56%+27.34% 25.97B
+0.47%+6.22%+39.36%-12.38% 19.98B
+1.82%-3.11%+245.72%+423.83% 17.84B
+0.94%+2.38%+24.83%+552.12% 16.24B
+0.73%+6.86%+42.84%+156.30% 13.3B
Average +0.97%+5.02%+52.38%+175.96% 28.72B
Weighted average by Cap. +0.68%+6.66%+61.06%+163.40%

Financials

2024 2025
Net sales - 3.9K 2.81 2.41 2.25 2.06 3.87 269.15 3.92 26.63 10.38 135.11 10.56 10.33 448.1
Net income -20.14B -14.54M -12.45M -11.64M -10.65M -20M -1.39B -20.26M -138M -53.63M -698M -54.56M -53.37M -2.31B -12.81B -9.25M -7.92M -7.4M -6.78M -12.72M -884M -12.89M -87.52M -34.12M -444M -34.7M -33.95M -1.47B
Net Debt -53.54B -38.65M -33.09M -30.94M -28.32M -53.16M -3.7B -53.86M -366M -143M -1.86B -145M -142M -6.15B -38.97B -28.14M -24.09M -22.53M -20.62M -38.7M -2.69B -39.21M -266M -104M -1.35B -106M -103M -4.48B
Logo MedPacto, Inc.
MedPacto, Inc. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops anticancer drugs and diagnostic kits including vactosertib, MA-B2 and others. The products are used as the treatment of multiple myeloma, lung cancer, stomach cancer, colon cancer, blood cancer, triple negative breast cancer and pancreatic cancer, among others.
Employees
-
Date Price Change Volume
26-08-21 ₩2,550.00 -1.54% 110,012
26-08-20 ₩2,590.00 +6.37% 348,594
26-08-19 ₩2,435.00 -3.75% 111,377
26-08-18 ₩2,530.00 -5.95% 141,822
26-08-14 ₩2,690.00 -1.47% 87,804
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A235980 Stock